Hikma Pharmaceuticals (LON:HIK)

Hikma Pharmaceuticals (LON:HIK)


Share Price
1,739.00 p
Change
-45 (-2.52 %)
Market Cap
£4,207.58 m
Proactive Investors - Run By Investors For Investors

Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC is a pharmaceutical company engaged the development, manufacture and marketing of a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms.

EPIC: HIK
Market: AIM:HIK
OTCBB:HKMPF
52-week High/Low: 2,089.00p / 1,290.00p
Sector: Pharma & Biotech
Market Cap: £4,207.58 m
Website: www.hikma.com
col 3
col 4
col 5
col 6

Hikma Pharmaceuticals Timeline

RNS
Fri
RNS
May 02 2019
RNS
April 15 2019
RNS
April 15 2019
RNS
April 01 2019
RNS
April 01 2019
RNS
March 18 2019

Columns Including HIK

VIEW ALL

Market Reports Including HIK

VIEW ALL

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use